Labetuzumab (anti-CEACAM5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175569-5MG / 5MG
CAS:219649-07-7
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175570-100ΜG / 100ΜG
CAS:1469876-18-3
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175570-10MG / 10MG
CAS:1469876-18-3
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175570-1MG / 1MG
CAS:1469876-18-3
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175570-5MG / 5MG
CAS:1469876-18-3
Lampalizumab (anti-Complement Factor D) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175571-100ΜG / 100ΜG
CAS:1278466-20-8
Lampalizumab (anti-Complement Factor D) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175571-10MG / 10MG
CAS:1278466-20-8
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175573-100ΜG / 100ΜG
CAS:1391726-30-9
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175573-10MG / 10MG
CAS:1391726-30-9
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175573-1MG / 1MG
CAS:1391726-30-9
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175573-5MG / 5MG
CAS:1391726-30-9
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175575-100ΜG / 100ΜG
CAS:1260393-98-3
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175575-10MG / 10MG
CAS:1260393-98-3
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175575-1MG / 1MG
CAS:1260393-98-3
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175575-5MG / 5MG
CAS:1260393-98-3
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175576-100ΜG / 100ΜG
CAS:1229575-09-0
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175576-10MG / 10MG
CAS:1229575-09-0
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175576-1MG / 1MG
CAS:1229575-09-0
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175576-5MG / 5MG
CAS:1229575-09-0
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175578-100ΜG / 100ΜG
CAS:1401812-88-1
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175578-10MG / 10MG
CAS:1401812-88-1
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175578-1MG / 1MG
CAS:1401812-88-1
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175578-5MG / 5MG
CAS:1401812-88-1
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175579-100ΜG / 100ΜG
CAS:1322627-61-1
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175579-10MG / 10MG
CAS:1322627-61-1
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175579-1MG / 1MG
CAS:1322627-61-1
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175579-5MG / 5MG
CAS:1322627-61-1
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175580-100ΜG / 100ΜG
CAS:1453362-55-4
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175580-10MG / 10MG
CAS:1453362-55-4
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175580-1MG / 1MG
CAS:1453362-55-4
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175580-5MG / 5MG
CAS:1453362-55-4
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175581-100ΜG / 100ΜG
CAS:166089-32-3
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175581-10MG / 10MG
CAS:166089-32-3
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175581-1MG / 1MG
CAS:166089-32-3
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175581-5MG / 5MG
CAS:166089-32-3
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175582-100ΜG / 100ΜG
CAS:1000676-41-4
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175582-10MG / 10MG
CAS:1000676-41-4
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175582-1MG / 1MG
CAS:1000676-41-4
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175582-5MG / 5MG
CAS:1000676-41-4
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175584-100ΜG / 100ΜG
CAS:2412004-88-5
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175584-10MG / 10MG
CAS:2412004-88-5
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175584-1MG / 1MG
CAS:2412004-88-5
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB175584-5MG / 5MG
CAS:2412004-88-5
Lorvotuzumab mertansine (anti-NCAM1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175586-100ΜG / 100ΜG
CAS:1008106-64-6
Lorvotuzumab mertansine (anti-NCAM1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175586-10MG / 10MG
CAS:1008106-64-6
Lorvotuzumab mertansine (anti-NCAM1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB175586-1MG / 1MG
CAS:1008106-64-6